Sustainability, also referred to as sustainable development, has, in the pharmaceutical industry, been, in the main, in the background, especially when it comes to facilities and engineering. In the few cases where dedicated individuals or companies have recognized the long-term benefits of being early adopters, it has been questioned as to its relevance. An element of this is the belief that sustainability is a fad word with short-term political relevance, or that it is just about sensible energy management at a time of high energy prices.
In recent years we have observed misunderstanding and confusion over correlation between the 2004 US Food and Drug Administration (FDA) environmental cleanliness requirements for sterile product manufacture and those of the European Medicines Agency EudraLex Volume 4, Annex 1.
In 1961, while working at Sandia Laboratory in New Mexico, Willis Whitfield and his colleagues developed the world’s first cleanroom and clean benches. These developments were instrumental for the electronics, aerospace, and later, pharmaceutical industries, where particulate contamination had to be minimized or eliminated.
Each year, ISPE celebrates innovations and advances in pharmaceutical manufacturing technology with its Facility of the Year Awards (FOYA) program. This year, we added a new category, Social Impact, to recognize companies that developed new standards and practices to prevent drug shortages and...
2020 ISPE Annual Meeting & Expo: Driving the Future of Pharma
The 2020 ISPE Annual Meeting & Expo will be ISPE’s first completely virtual Annual Meeting. As always, there will be great learning and networking opportunities—in fact, the digital...
The 2020 ISPE Annual Meeting & Expo will be ISPE’s first completely virtual Annual Meeting. As always, there will be great learning and networking opportunities—in fact, the digital format offers greater flexibility for attendees.